Two new phase 2 studies suggest that the investigational drug orforglipron, developed by Eli Lilly, shows promise in the treatment of obesity and type 2 diabetes. Currently, GLP-1 agonists (a class of medications utilized in the treatment of type 2 diabetes mellitus and obesity) approved for these conditions are administered via under the skin injection,
Brain Injury Awareness Month (recognized every June) serves as a crucial reminder of the devastating consequences of brain injuries, and the need for greater understanding and support for those affected. From mild concussions to severe traumatic brain injuries (TBIs), these injuries can significantly alter the lives of individuals and their loved ones. In this article,
In June, Canadians come together to raise awareness about the importance of men’s health during Canadian Men’s Health Month. This annual observance provides an opportunity to highlight the unique health challenges faced by men, promote preventive measures, and encourage proactive healthcare practices. With a focus on physical, mental, and emotional well-being, Canadian Men’s Health Month
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord. ALS primarily involves the degeneration and death of motor neurons, which are responsible for transmitting signals from the brain to the muscles, leading to a loss of voluntary muscle control.
National Health and Fitness Day (June 3rd) brings together people from all walks of life to celebrate the importance of leading a healthy and active lifestyle. This special day, observed annually, serves as a reminder of the power we hold to take charge of our well-being and make positive choices that benefit our physical and
A new population-based study, involving 22 million people, shows that autoimmune disorders now affect around one in ten individuals. These conditions pose a huge burden on individuals and upon wider society, and currently represent an enormous unmet clinical need. Autoimmune diseases are a group of disorders characterized by an abnormal immune response, where the immune
Artificial intelligence (AI) has already made significant contributions and changes to many industries, and clinical research is no exception. AI has the potential to revolutionize the way clinical trials are conducted, making them faster, more efficient, and more cost-effective. In this article, we will explore how AI could impact the clinical trial industry in the
Clinical research, like many industries, has become increasingly globalized during the 21st century. Emerging markets in Asia and South America offer access to diverse patient populations, a greater number of subjects for recruitment, more opportunity for global collaboration and increased inclusivity. The globalization of clinical trials reflects a dynamic and interconnected approach to advancing medical
Welcome back to our series of blogs honoring Clinical Trials Day 2023, celebrated on May 20th! Clinical trials are essential studies conducted to evaluate the safety, efficacy, and effectiveness of medical interventions, including drugs, treatments, devices, and diagnostic procedures. These trials follow a structured and rigorous process to generate reliable evidence for medical advancements, and
The US Food and Drug Administration (FDA) has granted approval to GlaxoSmithKline (GSK) for Arexvy, the world’s first vaccine designed to protect older adults against respiratory syncytial virus (RSV). RSV is a common respiratory virus that can cause serious illness, particularly in adults over 65 years of age, and in infants and young children. It